US2010286381A1PendingUtilityA1

Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3

58
Assignee: LEE SANG YUPPriority: Sep 28, 2001Filed: Jul 2, 2010Published: Nov 11, 2010
Est. expirySep 28, 2021(expired)· nominal 20-yr term from priority
Inventors:Sang Yup LeeNae-Choon YooSo Young YooHyun Cheol ChungKi Chang KeumWon Min YooKi-Jun Jeong
C12Q 1/6886C12Q 2600/156C12N 15/11C07K 16/243
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.

Claims

exact text as granted — not AI-modified
1 - 14 . (canceled) 
     
     
         15 . Method for using an isolated G-CSF mRNA or cDNA fragment which is missing exon 3 as a diagnostic cancer marker.

Join the waitlist — get patent alerts

Track US2010286381A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.